74593429 - HYALURONAN INDUCED TARGETING

Information

• Trademark
• 74593429

• Source

• Serial Number

  74593429

• International Classifications

  • 5 - Pharmaceutical and veterinary preparations
  • 42 - Scientific and technological services and research and design relating thereto

• Filing Date

  November 01, 1994
  30 years ago

• Transaction Date

  October 24, 2004
  20 years ago

• Status Date

  August 25, 1997
  27 years ago

• Location Date

  August 29, 1997
  27 years ago

• Status Code

  602

• Current Location

  FILE REPOSITORY (FRANCONIA)

  Employee Name

  MANDIR, FREDERICK M

• Attorney Docket Number

  TM-1814

  Attorney Name

  IVOR M. HUGHES

  Law Office Assigned Location Code

  L50

• Owners

  • HYAL PHARMACEUTICAL CORPORATION

Case File Statements

• D10000: "HYALURONAN"
• GS0051: pharmaceutical preparations comprising hyaluronan, adapted for the topical, injectable, and intravenous treatment of the following - cancer, increasing activity of macrophages; reduction of swelling in the brain of person suffering brain trauma; herpes, canker sore, shingles; renal failure, cardiac insufficiency, hypertension, edema; infection, acne, monoucleosis; transplants; inflammation, elminiation of tumor breakdown material (toxins and debris), decreasing side effects, relief of pain; detoxification; bronchodilation; vascular ischemia; HIV (AIDS); diabetes; post-menopause; prevention of topical infection; reduction of swelling; hypertension, cardiac insufficiency; prostaglandin synthesis inhibition; enhancement of oxygenation of tissue by perfusion fluid bathing of the tissue (for transplantation purposes); sub-retinal neovascularization and as an adjunct to the treatment of cancer to prevent metastasis; arthitis or pannus; cancer tumours; inhibiting angiogenesis; controlling angiogenesis; regressing angiogenesis; basal cell carcinoma; actinic keratones; liver spots; squamous cell tumours; metastatic cancer of the breast to the skin; primary and metastatic melanoma of the skin; malignancies and/or tumor of the skin; genital warts (condyloma acuminata); cervical cancer; Human Papilloma Virus (HPV); psoriasis, corns on the feet; and hair loss on the heads of pregnant women; topical treatment of pain in the skin and or exposed tissue; clearing of atherosclerosis; prevention of arterial restenosis after balloon angioplasty; macrophage infilitration
• GS0421: acquisition, development and licensing of intellectual property technology regarding pharmaceutical preparations comprising hyaluronan, adapted for the topical, injectable and intravenous treatment of medical conditions and disease in humans

Case File Event Statements

• 8/25/1997 - 27 years ago

  8 - ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE Type: ABN2

• 1/29/1997 - 28 years ago

  7 - INQUIRY AS TO SUSPENSION MAILED Type: CNSI

• 6/6/1996 - 28 years ago

  6 - UNRESPONSIVE/DUPLICATE PAPER RECEIVED Type: UNPR

• 6/4/1996 - 28 years ago

  5 - INQUIRY AS TO SUSPENSION MAILED Type: CNSI

• 1/6/1996 - 29 years ago

  4 - LETTER OF SUSPENSION MAILED Type: CNSL

• 10/16/1995 - 29 years ago

  3 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA

• 4/18/1995 - 29 years ago

  2 - NON-FINAL ACTION MAILED Type: CNRT

• 3/17/1995 - 29 years ago

  1 - ASSIGNED TO EXAMINER Type: DOCK